Biological monitoring of hospital personnel occupationally exposed to antineoplastic agents.
about
Sampling and mass spectrometric analytical methods for five antineoplastic drugs in the healthcare environmentReduction in surface contamination with antineoplastic drugs in 22 hospital pharmacies in the US following implementation of a closed-system drug transfer deviceReduction in Surface Contamination With Cyclophosphamide in 30 US Hospital Pharmacies Following Implementation of a Closed-System Drug Transfer DeviceOccupational exposure to chemotherapy of pharmacy personnel at a single centreA probabilistic assessment of the impact of interventions on oncology nurses' exposure to antineoplastic agentsEco-friendly ionic liquid assisted capillary electrophoresis and α-acid glycoprotein-assisted liquid chromatography for simultaneous determination of anticancer drugs in human fluids.Risks to health professionals from hazardous drugs in Iran: a pilot study of understanding of healthcare team to occupational exposure to cytotoxics.Monitoring of oxidative stress in nurses occupationally exposed to antineoplastic drugs.Oxidative stress induced in nurses by exposure to preparation and handling of antineoplastic drugs in Mexican hospitals: a multicentric study.High-dose treosulfan in conditioning prior to hematopoietic stem cell transplantation.Occupational exposure to anti-cancer drugs: A review of effects of new technology.5-Fluorouracil induces apoptosis in rat cardiocytes through intracellular oxidative stress.Antineoplastic drugs and their analysis: a state of the art review.Monitoring of platinum surface contamination in seven Dutch hospital pharmacies using inductively coupled plasma mass spectrometry.Biological monitoring of nurses exposed to doxorubicin and epirubicin by a validated liquid chromatography/fluorescence detection method.Environmental and biological monitoring of platinum-containing drugs in two hospital pharmacies using positive air pressure isolators.Simple and reliable HPLC method for the monitoring of methotrexate in osteosarcoma patients.Occupational exposure to antineoplastic drugs in seven Italian hospitals: the effect of quality assurance and adherence to guidelines.Evaluation of a closed-system cytotoxic transfer device in a pharmaceutical isolator.Occupational risk assessment of genotoxicity and oxidative stress in workers handling anti-neoplastic drugs during a working week.Simultaneous determination of cyclophosphamide, ifosfamide, doxorubicin, epirubicin and daunorubicin in human urine using high-performance liquid chromatography/electrospray ionization tandem mass spectrometry: bioanalytical method validation.Hygienic guidance values for wipe sampling of antineoplastic drugs in Swedish hospitals.Antineoplastic drugs determination by HPLC-HRMS(n) to monitor occupational exposure.Comparison of Decontamination Efficacy of Cleaning Solutions on a Biological Safety Cabinet Workbench Contaminated by Cyclophosphamide.Wipe sampling procedure coupled to LC-MS/MS analysis for the simultaneous determination of 10 cytotoxic drugs on different surfaces.Environmental contamination, product contamination and workers exposure using a robotic system for antineoplastic drug preparation.
P2860
Q23914149-3DEDA8E6-0D5B-4D3F-AA79-85FCCE37D1DCQ23919324-8AD00FBA-C43A-4897-9695-6E1BF4485B0AQ28391685-4295FA03-1440-4458-A529-86E693E5208DQ28392801-9A5D5DBE-4719-473F-BDDF-9740C3E9A9A2Q28397365-9539A90B-0F27-4059-A3BC-8365E7201E69Q35423745-C899DD50-98AD-49A4-858F-4110DB6C78A3Q35726332-8BCB71E2-ACC3-47D0-B4C9-1404A6B6E118Q35919639-01ECA35E-5FEE-4CEB-A8C6-0AF0A42DDC44Q37641350-211B9B14-5B68-4471-9D1E-2FAA65F45DF2Q37788219-111F434F-DE44-4AEA-942B-414C80C02236Q38131440-DF35A54F-1198-465F-8358-5B5C45724BF1Q39311982-00B9F551-7B1A-4DF8-9756-CE9082384806Q39339684-0FAFB967-15D0-4CBD-A8E4-2579D7EA1139Q42583436-48C70329-54F0-4F66-A5DE-034761F319CEQ43064194-05DA5A64-4152-4AC0-ABFE-0FBFC43B3C48Q43692507-8867761F-E045-42EA-9A8B-D60BFD2E1FC7Q44252346-D52486F3-88C5-4951-8498-0EBB9ADF3C10Q44449596-7834C46B-7238-471A-9F32-5A9C8A3A5F0BQ45406098-2493AFE1-EF39-48A5-829E-3D77AAB97617Q45770434-629F5112-ED32-4A90-ACFA-91B33C63003AQ46455772-7FC6D04F-997B-4085-8AA1-757C8C2D975EQ47630409-7F492AAA-D588-4B50-A208-F6F62091405BQ48179474-24FF5A93-2808-4268-BDCE-0714ABB46937Q49335562-DDA573F6-5D90-4F93-964B-6AB0C3A3E064Q51025294-FE47133C-588B-44E7-B68B-5C3DD12DB1C7Q51108571-633ADF54-804F-4919-872C-1A1E52E99471
P2860
Biological monitoring of hospital personnel occupationally exposed to antineoplastic agents.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年学术文章
@wuu
2002年学术文章
@zh
2002年学术文章
@zh-cn
2002年学术文章
@zh-hans
2002年学术文章
@zh-my
2002年学术文章
@zh-sg
2002年學術文章
@yue
2002年學術文章
@zh-hant
name
Biological monitoring of hospi ...... osed to antineoplastic agents.
@en
Biological monitoring of hospi ...... osed to antineoplastic agents.
@nl
type
label
Biological monitoring of hospi ...... osed to antineoplastic agents.
@en
Biological monitoring of hospi ...... osed to antineoplastic agents.
@nl
prefLabel
Biological monitoring of hospi ...... osed to antineoplastic agents.
@en
Biological monitoring of hospi ...... osed to antineoplastic agents.
@nl
P1433
P1476
Biological monitoring of hospi ...... posed to antineoplastic agents
@en
P2093
Anna Ronchi
Claudio Minoia
P356
10.1016/S0378-4274(02)00163-7
P577
2002-08-01T00:00:00Z